Clinical Trial Update: Safety and Immunogenicity of an Inactivated Pandemic Influenza Vaccine [Phase 2]

View source ↗

Summary

This Phase 2 trial reports safety and immunogenicity data for an inactivated pandemic influenza vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pandemic Influenza

Drugs mentioned

• Inactivated pandemic influenza vaccine (influenza vaccine, inactivated, pandemic strain)

Snippet

Sponsor: Sinovac Biotech Co., Ltd | Conditions: Pandemic Influenza, Prevention | Phase 2 | Status: COMPLETED